Gene · 715
Papers2,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 2,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prospective clinical investigations of children with periodontal Ehlers-Danlos syndrome identify generalized lack of attached gingiva as a pathognomonic feature. | Genet Med | 2021 | 33005042 | PubTator, text mining | PubMed |
| Molar mass effect in food and health. | Food Hydrocoll | 2021 | 32895590 | PubTator, text mining | PubMed |
| Headless C1q: a new molecular tool to decipher its collagen-like functions. | FEBS J | 2021 | 32869492 | PubTator, text mining | PubMed |
| Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence. | JAMA Psychiatry | 2021 | 32857162 | PubTator, text mining | PubMed |
| SMARCA4 promotes benign skin malignant transformation into melanoma through Adherens junction signal transduction. | Clin Transl Oncol | 2021 | 32720055 | PubTator, text mining | PubMed |
| Tackling COVID-19 infection through complement-targeted immunotherapy. | Br J Pharmacol | 2021 | 32643798 | PubTator, text mining | PubMed |
| Diagnostic and Prognostic Significance of Complement in Patients With Alcohol-Associated Hepatitis. | Hepatology | 2021 | 32557728 | PubTator, text mining | PubMed |
| Glial cell diversity and methamphetamine-induced neuroinflammation in human cerebral organoids. | Mol Psychiatry | 2021 | 32051547 | PubTator, text mining | PubMed |
| Understanding the relevance of protein corona in nanoparticle-based therapeutics and diagnostics. | RSC Adv | 2020 | 35515780 | PubTator, text mining | PubMed |
| Overexpression of SEZ6L2 predicts poor prognosis in patients with cholangiocarcinoma. | Transl Cancer Res | 2020 | 35117286 | PubTator, text mining | PubMed |
| "Complimenting the Complement": Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma. | Front Oncol | 2020 | 33718121 | PubTator, text mining | PubMed |
| Further Evidence of a Recessive Variant in COL1A1 as an Underlying Cause of Ehlers-Danlos Syndrome: A Report of a Saudi Founder Mutation. | Glob Med Genet | 2020 | 33693443 | PubTator, text mining | PubMed |
| The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia. | Front Immunol | 2020 | 33643290 | PubTator, text mining | PubMed |
| Heterozygous P32/C1QBP/HABP1 Polymorphism rs56014026 Reduces Mitochondrial Oxidative Phosphorylation and Is Expressed in Low-grade Colorectal Carcinomas. | Front Oncol | 2020 | 33628739 | PubTator, text mining | PubMed |
| Identification of Neuronal Pentraxins as Synaptic Binding Partners of C1q and the Involvement of NP1 in Synaptic Pruning in Adult Mice. | Front Immunol | 2020 | 33628204 | PubTator, text mining | PubMed |
| A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma. | Front Cell Dev Biol | 2020 | 33614625 | PubTator, text mining | PubMed |
| Progress and Clinical Application of Single-Cell Transcriptional Sequencing Technology in Cancer Research. | Front Oncol | 2020 | 33614479 | PubTator, text mining | PubMed |
| Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer. | Front Oncol | 2020 | 33614473 | PubTator, text mining | PubMed |
| Human Cerebral Cortex Proteome of Fragile X-Associated Tremor/Ataxia Syndrome. | Front Mol Biosci | 2020 | 33585555 | PubTator, text mining | PubMed |
| Complement Activation in Kidneys of Patients With COVID-19. | Front Immunol | 2020 | 33584662 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/715/papers?page=52